Dendritic cell-based vaccine for pancreatic cancer in Japan
about
The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.Dendritic cell vaccines: A review of recent developments and their potential pediatric application.HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activationAn overview of polyamine metabolism in pancreatic ductal adenocarcinoma.
P2860
Dendritic cell-based vaccine for pancreatic cancer in Japan
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Dendritic cell-based vaccine for pancreatic cancer in Japan
@ast
Dendritic cell-based vaccine for pancreatic cancer in Japan
@en
Dendritic cell-based vaccine for pancreatic cancer in Japan
@nl
type
label
Dendritic cell-based vaccine for pancreatic cancer in Japan
@ast
Dendritic cell-based vaccine for pancreatic cancer in Japan
@en
Dendritic cell-based vaccine for pancreatic cancer in Japan
@nl
prefLabel
Dendritic cell-based vaccine for pancreatic cancer in Japan
@ast
Dendritic cell-based vaccine for pancreatic cancer in Japan
@en
Dendritic cell-based vaccine for pancreatic cancer in Japan
@nl
P2093
P2860
P356
P1476
Dendritic cell-based vaccine for pancreatic cancer in Japan
@en
P2093
Masanori Kobayashi
Masato Okamoto
Sadamu Homma
Shigeo Koido
Yoshikazu Yonemitsu
P2860
P356
10.4292/WJGPT.V7.I1.133
P407
P577
2016-02-06T00:00:00Z